Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Marimastat in Patients With Disabling Malformations and No Other Treatment Options

NCT00261391 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT00261391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Marimastat in Patients With Disabling Malformations and No Other Treatment Options
Lead sponsor
Boston Children's Hospital
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2000
Completion date
October 31, 2007
Enrollment
9
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vascular anomalies